Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
Abstract Background and aim Hepatocellular carcinoma (HCC) is a highly immunogenic tumor and the third leading cause of cancer-related deaths worldwide with an increasing incidence. Therefore, the combination of immunotherapy with other approaches, such as anti-angiogenic agents and local area thera...
Saved in:
Main Authors: | Gui-Lin Xie, Zhi-Han Zhong, Tai-Wei Ye, Zun-Qiang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-025-02778-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma
by: Toru Ishikawa, et al.
Published: (2024-12-01) -
Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
by: Young Mi Hong
Published: (2024-12-01) -
Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment
by: Xuexia Liang, et al.
Published: (2024-12-01) -
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
by: Zhang G, et al.
Published: (2025-01-01) -
Radiofrequency ablation of hepatocellular carcinoma guided by real-time physics-based ablation simulation: a prospective study
by: Eric K. Hoffer, et al.
Published: (2024-12-01)